Of potential clinical interest are properties such as anti-obesity, anti-lipocytes, anti-pancreatic lipase, anti-dyslipidemia, anti-atherosclerosis (including anti-low density lipoprotein (LDL) oxidation, anti-15-lipoxygease, anti-tyrosinase), anti-diabetes, anti-hypertension, and anti-tumour activities. This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.